HER2 amplification, overexpression and score criteria in esophageal adenocarcinoma
Modern Pathology2011Vol. 24(7), pp. 899–907
Citations Over TimeTop 10% of 2011 papers
Yingchuan Hu, Santhoshi Bandla, Tony E. Godfrey, Dongfeng Tan, James D. Luketich, Arjun Pennathur, Xing Qiu, David G. Hicks, Jeffrey H. Peters, Zhongren Zhou
Related Papers
- → Fluorescent in situ hybridization on tissue microarrays: challenges and solutions(2007)52 cited
- → HER2 Positivity in Breast Carcinoma: A Comparison of Chromogenic In Situ Hybridization With Fluorescence In Situ Hybridization in Tissue Microarrays, With Targeted Evaluation of Intratumoral Heterogeneity by In Situ Hybridization(2005)43 cited
- → Feasibility of Using Tissue Microarrays for the Assessment of HER-2 Gene Amplification by Fluorescence In Situ Hybridization in Breast Carcinoma(2004)36 cited
- → Comparing Fluorescence In Situ Hybridization and Chromogenic In Situ Hybridization Methods to Determine the HER2/neu Status in Primary Breast Carcinoma using Tissue Microarray(2003)53 cited
- → Abstract P3-10-24: Fibroblast Growth Factor Receptor 1 Amplification and Overexpression in Breast Cancer Tissue Microarrays Using Chromogenic In Situ Hybridization and Immunohistochemistry(2010)1 cited